Frontiers | High levels of kappa free light chain synthesis predict cognitive decline in relapsing-remitting multiple sclerosis
Living With - HealthTree for Multiple Myeloma
![PE Anti-Kappa light chain antibody [TB28-2] (ab131602) | Abcam](https://www.abcam.com/ps/products/131/ab131602/Images/ab131602-273625-anti-kappa-light-chain-antibody-tb28-2-prediluted-phycoerythrin-flow-cytometry.jpg "PE Anti-Kappa light chain antibody [TB28-2] (ab131602) | Abcam")
PE Anti-Kappa light chain antibody [TB28-2] (ab131602) | Abcam
Frontiers | Understanding AL amyloidosis with a little help from in vivo models
Biomedicines | Free Full-Text | Serum Free Light-Chain Ratio at Diagnosis Is Associated with Early Renal Damage in Multiple Myeloma: A Case Series Real-World Study
SciELO - Brasil - Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies Serum free light chain assays not total light chain
Immunoglobulin classes
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia
Follow-up of IgD-κ multiple myeloma by monitoring free light chains and total heavy chain IgD: A case report
Guide to Antibody structure and isotypes | Abcam
Polyclonal versus monoclonal immunoglobulin-free light chains quantification - Giuseppe Di Noto, Elena Cimpoies, Alessandra Dossi, Lucia Paolini, Annalisa Radeghieri, Luigi Caimi, Doris Ricotta, 2015
The renal range of the κ/λ sFLC ratio: best strategy to evaluate multiple myeloma in patients with chronic kidney disease | BMC Nephrology | Full Text
JPM | Free Full-Text | Laboratory and Clinical Settings of Heavy/Light Chain (HLC) Assays in the Management of Monoclonal Gammopathies and Multiple Myeloma
Nephron Power: February 2016
Providence Health Care Test Catalog
Frontiers | Case Report: A case of IgD lambda/lambda Multiple Myeloma in patient with acute renal failure and without monoclonal spike in serum electrophoresis
trend in serum free light chain levels and kappa-lambda free light... | Download Scientific Diagram
Serum free light chain assessment in monoclonal gammopathy and kidney disease | Nature Reviews Nephrology
SARS-CoV-2 infection associated with monoclonal gammopathy. A case report based on the study of minimally invasive ultrasound-guided autopsy | Revista Española de Patología
IJMS | Free Full-Text | Free Light Chains κ and λ as New Biomarkers of Selected Diseases
Antibodies gone bad – the molecular mechanism of light chain amyloidosis - Absmeier - 2023 - The FEBS Journal - Wiley Online Library
Measuring M-Protein SPEP, UPEP Tests | Int'l Myeloma Fdn
Evaluation of monoclonal gammopathies - Differential diagnosis of symptoms | BMJ Best Practice US
Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses - ScienceDirect
Serum immunoglobulin free light chains and their association with clinical phenotypes, serology and activity in patients with IgG4-related disease | Scientific Reports
